title: [Immunomodulation in Pseudomonas urinary infection].
abstract: The urological department is as a rule of department with the highest incidence of nosocomial infections. They are often caused by Pseudomonas aeruginosa. In 1992 the authors started to use prophylactic immunization with antipseudomonas vaccine PSAEVA in 58 patients indicated for surgery on account of an prostate adenoma. During and after operation the incidence of Pseudomonas infection in immunized and control patients was compared. In the immunized group the incidence after operation was 1.72%, in the control group 12%. The drop of Pseudomonas infections in operated patients immunized with the anti-pseudomonas vaccine as compared with non-immunized ones was by 10.28% lower which is statistically significant--p.0.05.
authors.affiliation: Urologická klinika FN KV, Praha.
authors.forename: M
authors.initials: M
authors.lastname: Urban
authors.forename: L
authors.initials: L
authors.lastname: Tamele
mesh_terms: D001428:Bacterial Vaccines; D003428:Cross Infection / Q000517:prevention & control*; D006801:Humans; D008297:Male; D011183:Postoperative Complications / Q000517:prevention & control; D011468:Prostatectomy; D011552:Pseudomonas Infections / Q000517:prevention & control*; D011550:Pseudomonas aeruginosa / Q000276:immunology*; D014552:Urinary Tract Infections / Q000517:prevention & control*
chemical_list: D001428:Bacterial Vaccines